Applied Genetic Technologies reported $87.19M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alimera Sciences ALIM:US $ 49.93M 8.59M
Applied Genetic Technologies AGTC:US $ 87.19M 5.18M
Avrobio Inc AVRO:US $ 175.34M 28.49M
Biogen BIIB:US $ 23614.4M 262.9M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Celldex Therapeutics CLDX:US $ 424.04M 20.61M
Cti Biopharma CTIC:US $ 131.44M 59M
Gilead Sciences GILD:US $ 63080M 4872M
Insmed INSM:US $ 1.15B 90.19M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Life Technologies LIFE:US $ 104.78M 10.76M
Ophthotech OPHT:US $ 352.7M 36.65M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Rigel Pharmaceuticals RIGL:US $ 149.07M 18.25M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M